Abstract
Very low density lipoprotein receptors (VLDLR) including type I and type II are known to affect cell functions by binding to its extracellular ligands. However, the effect of these ligands on VLDLR expression remains elusive. Tissue factor pathway inhibitor (TFPI) and urokinase plasminogen activator and plasminogen activator inhibitor 1 (uPA-PAI-1) complex, two ligands of VLDLR, were used to examine their effects on VLDLR expression. TFPI treatment decreased type II VLDLR expression, inhibited cell proliferation and migration, and degradated beta-catenin in SGC7901 cells. However, uPA-PAI-1 complex, increased type II VLDLR expression with promoted cell proliferation and migration and stabilization of beta-catenin. These results indicated that extracellular ligands can change the expression of type II VLDLR to affect cell proliferation and migration.
References
Oct 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·S TakahashiT Yamamoto
Apr 1, 1994·Human Molecular Genetics·J C WebbA K Soutar
Oct 2, 1998·Journal of Biochemistry·H IijimaT T Yamamoto
Mar 6, 1999·The Journal of Biological Chemistry·D J WebbS L Gonias
Jan 11, 2000·Archives of Pathology & Laboratory Medicine·Y NakamuraE Kumamaru
Jul 6, 2000·Trends in Cardiovascular Medicine·K D Mehta, L Miller
Sep 2, 2000·The Journal of Biological Chemistry·H Y Hsu, Y C Twu
Feb 24, 2001·Heart and Vessels·Y WadaY Maruyama
Mar 27, 2001·The Journal of Cell Biology·D J WebbS L Gonias
Mar 30, 2001·The Journal of Biological Chemistry·T A HembroughD K Strickland
Jun 21, 2002·Trends in Cell Biology·Anders Nykjaer, Thomas E Willnow
Dec 10, 2002·Biochemical and Biophysical Research Communications·Hiroko Shirotani-IkejimaToshiyuki Miyata
Jul 8, 2003·The Journal of Pathology·Ivan Stamenkovic
Jul 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hippokratis KiarisAnastasios Kalofoutis
Dec 8, 2004·Current Cancer Drug Targets·Hue H LuuTong-Chuan He
May 11, 2005·World Journal of Gastroenterology : WJG·Tao ChenShen Qu
Jul 26, 2005·Molecular Cell·Qingqing DingMien-Chie Hung
Oct 30, 2007·Translational Research : the Journal of Laboratory and Clinical Medicine·Xiaoran QinLihong Ye
Jan 27, 2009·Life Sciences·Pu YangShen Qu
Citations
Nov 5, 2010·BMC Cancer·Lei HeShen Qu
Dec 3, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M RíosR Señarís
Aug 1, 2015·PloS One·Chia-Yi SuMichael Hsiao
Apr 22, 2017·Journal of Atherosclerosis and Thrombosis·Sadao Takahashi
May 25, 2011·The Journal of Biological Chemistry·Blake J CochranMarie Ranson
Apr 12, 2017·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Lei HeZhi-Guo Liu
Feb 20, 2020·Scientific Reports·Isabel ÁlvarezFélix Goyache